-
Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review
15 Apr 2025 14:11 GMT
… to SN-38, an irinotecan metabolite with TOP1 inhibition … patients with small cell lung cancer. Lung Cancer. 2018;115:116–120 … patients with small cell lung cancer. Lung Cancer. 2020;147:237–243 … in metastatic small cell lung cancers and patient-derived models. …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Cancer Patients’ Behavior and Perception on the Use of Medical Foods and Dietary Supplements During Chemotherapy
09 May 2025 10:21 GMT
… regimens (capecitabine with oxaliplatin or irinotecan, 5-fluorouracil with leucovorin or … intakes in non-small cell lung cancer patients receiving chemotherapy. Thai JPEN …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … metastatic non-small cell lung cancer, in combination with … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells
19 Feb 2025 00:32 GMT
… lung cancer (NSCLC) forms approximately 80% of all lung cancer … with amlodipine.
Discussion
Lung cancer, specifically NSCLC, continues … pathway after treating lung cancer cells A549 with … N. Simvastatin enhances irinotecan-induced apoptosis in prostate …
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11
07 May 2025 11:24 GMT
… or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating … every 3 weeks or either irinotecan (N=55) 150 mg… or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… include doxorubicin, pirarubicin, irinotecan, oxaliplatin, cisplatin, gemcitabine … drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis … assessment of lung cancer resection specimens …
-
Book explores the fight against cancer through plant-based therapies
06 May 2025 21:44 GMT
… -synthetic drugs like topotecan and irinotecan, used to treat ovarian, lung … used to treat small-cell lung cancer and testicular cancer.
Similarly, Catharanthus … treatment of ovarian, breast and lung cancers.
Additionally, the book highlights the …
-
Dr Strosberg on Research Clarifying the Role of Obrixtamig in SCLC and Other Neuroendocrine Cancers
06 May 2025 03:29 GMT
… with extensive-stage small cell lung cancer (SCLC), extrapulmonary neuroendocrine carcinomas (NECs … as FOLFIRINOX (leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin) may be …
-
New Therapies Expand Options in Recurrent Small Cell Lung Cancer
14 Nov 2024 00:03 GMT
… to managing recurrent small cell lung cancer (SCLC), especially in patients who … we had were topotecan and irinotecan, but as of May of …
About
© 1995-2025